Yu‐Ching Cheng

3.9k total citations · 1 hit paper
31 papers, 958 citations indexed

About

Yu‐Ching Cheng is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Yu‐Ching Cheng has authored 31 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Physiology and 6 papers in Epidemiology. Recurrent topics in Yu‐Ching Cheng's work include Smoking Behavior and Cessation (7 papers), Traditional Chinese Medicine Analysis (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Yu‐Ching Cheng is often cited by papers focused on Smoking Behavior and Cessation (7 papers), Traditional Chinese Medicine Analysis (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Yu‐Ching Cheng collaborates with scholars based in Taiwan, United States and Australia. Yu‐Ching Cheng's co-authors include Ching‐Yuan Wu, Yao‐Hsu Yang, Li‐Hsin Shu, Yu‐Shih Lin, Jrhau Lung, Braxton D. Mitchell, John W. Cole, Steven J. Kittner, Mary J. Sparks and Kathleen A. Ryan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stroke and American Journal of Public Health.

In The Last Decade

Yu‐Ching Cheng

31 papers receiving 939 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase

2020 225 citations Jrhau Lung, Yu‐Shih Lin et al. Journal of Medical Virology profile →

Peers

Yu‐Ching Cheng

PRM

PHYSI

Ji Youn Youn United States

Jakub Rosik Poland

Filip Machaj Poland

Chun-Ling Liang China

Dayong Cai China

Agnieszka Seremak‐Mrozikiewicz Poland

Fen Jiang China

Jihan Huang China

Mehdi Koushki Iran

Mohammed M. Al‐Harbi Saudi Arabia

Ji Youn Youn United States

Yu‐Ching Cheng

389 ×1.6

125 ×0.7

PRM

127 ×0.9

146 ×1.1

PHYSI

60 ×0.4

Citations per year, relative to Yu‐Ching Cheng Yu‐Ching Cheng (= 1×) peers Ji Youn Youn

Countries citing papers authored by Yu‐Ching Cheng

Since Specialization

Citations

This map shows the geographic impact of Yu‐Ching Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ching Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ching Cheng more than expected).

Fields of papers citing papers by Yu‐Ching Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ching Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ching Cheng. The network helps show where Yu‐Ching Cheng may publish in the future.

Co-authorship network of co-authors of Yu‐Ching Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ching Cheng. A scholar is included among the top collaborators of Yu‐Ching Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ching Cheng. Yu‐Ching Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kasza, Karin A., Zhiqun Tang, Young Sik Seo, et al.. (2024). Divergence in Cigarette Discontinuation Rates by Use of Electronic Nicotine Delivery Systems (ENDS): Longitudinal Findings From the United States PATH Study Waves 1–6. Nicotine & Tobacco Research. 27(2). 236–243. 11 indexed citations

Edwards, Kathryn C., Michael J. Halenar, Cristine D. Delnevo, et al.. (2023). Patterns of Premium and Nonpremium Cigar Use in the United States: Findings from Wave 6 (2021) of the Population Assessment of Tobacco and Health Study. Nicotine & Tobacco Research. 25(Supplement_1). S5–S15. 4 indexed citations

Wu, Ching‐Yuan, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2023). The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution. Heliyon. 9(7). e17701–e17701. 2 indexed citations

Ashley, David L., Wanzhe Zhu, Lanqing Wang, et al.. (2022). Variability in Urinary Nicotine Exposure Biomarker Levels Between Waves 1 (2013–2014) and 2 (2014–2015) in the Population Assessment of Tobacco and Health Study. Nicotine & Tobacco Research. 25(4). 616–623. 1 indexed citations

Chang, Geng‐He, Yu‐Ching Cheng, Ching‐Yuan Wu, et al.. (2022). Nasal irrigation with licorice extract (Glycyrrhiza glabra) in treating nasal polyps by reducing fibroblast differentiation and extracellular matrix production in TGF-β1-stimulated nasal polyp-derived fibroblasts by inhibiting the MAPK/ERK-1/2 pathway – an in vitro and in clinic study. BMC Complementary Medicine and Therapies. 22(1). 313–313. 5 indexed citations

Yang, Jen‐Tsung, I‐Neng Lee, Chun‐Han Chen, et al.. (2022). Gallic Acid Enhances the Anti-Cancer Effect of Temozolomide in Human Glioma Cell Line via Inhibition of Akt and p38-MAPK Pathway. Processes. 10(3). 448–448. 13 indexed citations

Tsai, Ming‐Shao, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2022). Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations. Biomedicine & Pharmacotherapy. 149. 112802–112802. 9 indexed citations

Chang, Geng‐He, Yu‐Shih Lin, Yu‐Ching Cheng, et al.. (2021). Nasal irrigation with Glycyrrhiza glabra extract for treatment of allergic rhinitis – A study of in vitro, in vivo and clinical trial. Journal of Ethnopharmacology. 275. 114116–114116. 19 indexed citations

Tsai, Ming‐Shao, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2021). GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2. Biomedicine & Pharmacotherapy. 142. 112011–112011. 10 indexed citations

10.

Wu, Ching‐Yuan, Yao‐Hsu Yang, Yu‐Shih Lin, et al.. (2021). Dihydroisotanshinone I induced ferroptosis and apoptosis of lung cancer cells. Biomedicine & Pharmacotherapy. 139. 111585–111585. 52 indexed citations

11.

Yang, James Chih‐Hsin, et al.. (2020). Short-Term Clinical and Oncological Outcome of Prolonging Operation Interval After Neoadjuvant Chemoradiotherapy for Locally Advanced Middle and Low Rectal Cancer. SHILAP Revista de lepidopterología. 2 indexed citations

12.

Lung, Jrhau, Yu‐Shih Lin, Yao‐Hsu Yang, et al.. (2020). The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase. Journal of Medical Virology. 92(6). 693–697. 225 indexed citations breakdown →

13.

Wu, Ching‐Yuan, et al.. (2020). GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies. Biomedicine & Pharmacotherapy. 132. 110816–110816. 28 indexed citations

14.

Lin, Yu‐Shih, Ching‐Yuan Wu, Yao‐Hsu Yang, et al.. (2019). Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells. Frontiers in Pharmacology. 10. 1226–1226. 94 indexed citations

15.

Lin, Yu‐Shih, Yao‐Hsu Yang, Chun‐Liang Lin, et al.. (2018). Antrodia cinnamomea extract inhibits the proliferation of tamoxifen-resistant breast cancer cells through apoptosis and skp2/microRNAs pathway. BMC Complementary and Alternative Medicine. 18(1). 152–152. 32 indexed citations

16.

Yang, Yao‐Hsu, Chun‐Liang Lin, Wei‐Yu Lin, et al.. (2018). Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway. BMC Pharmacology and Toxicology. 19(1). 5–5. 22 indexed citations

17.

Yang, Jen‐Tsung, I‐Neng Lee, Fung‐Jou Lu, et al.. (2017). Propyl Gallate Exerts an Antimigration Effect on Temozolomide-Treated Malignant Glioma Cells through Inhibition of ROS and the NF-κB Pathway. Journal of Immunology Research. 2017. 1–12. 14 indexed citations

18.

Huang, Wen‐Shih, Feng‐Che Kuan, Li‐Hsin Shu, et al.. (2017). Danshen improves survival of patients with colon cancer and dihydroisotanshinone I inhibit the proliferation of colon cancer cells via apoptosis and skp2 signaling pathway. Journal of Ethnopharmacology. 209. 305–316. 40 indexed citations

19.

Cheng, Yu‐Ching, et al.. (2013). Magnetic Resonance Imaging of Rhabdomyolysis: Muscle Necrosis Versus Ischemia. 38(4). 143–148. 9 indexed citations

20.

Hamedani, Ali G., John W. Cole, Yu‐Ching Cheng, et al.. (2011). Factor V Leiden and Ischemic Stroke Risk: The Genetics of Early Onset Stroke (GEOS) Study. Journal of Stroke and Cerebrovascular Diseases. 22(4). 419–423. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact